Artigos de revistas sobre o tema "GB recurrence"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "GB recurrence".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Stadlbauer, Andreas, Ilker Eyüpoglu, Michael Buchfelder, Arnd Dörfler, Max Zimmermann, Gertraud Heinz e Stefan Oberndorfer. "Vascular architecture mapping for early detection of glioblastoma recurrence". Neurosurgical Focus 47, n.º 6 (dezembro de 2019): E14. http://dx.doi.org/10.3171/2019.9.focus19613.
Texto completo da fonteStadlbauer, Andreas, Stefan Oberndorfer, Max Zimmermann, Bertold Renner, Michael Buchfelder, Gertraud Heinz, Arnd Doerfler, Andrea Kleindienst e Karl Roessler. "Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans". Journal of Cerebral Blood Flow & Metabolism 40, n.º 3 (7 de fevereiro de 2019): 528–38. http://dx.doi.org/10.1177/0271678x19827885.
Texto completo da fonteLessi, F., M. Morelli, P. Aretini, M. Menicagli, S. Franceschi, F. Pasqualetti, C. Gambacciani, A. Di Stefano, O. Santonocito e C. M. Mazzanti. "P14.01.B Isolation and characterization of circulating tumor cells in a glioblastoma case with recurrence at distance and correlation with tumor mutational status". Neuro-Oncology 24, Supplement_2 (1 de setembro de 2022): ii82. http://dx.doi.org/10.1093/neuonc/noac174.286.
Texto completo da fonteBeppu, Takaaki, Yuichi Sato, Toshiaki Sasaki, Kazunori Terasaki e Kuniaki Ogasawara. "NI-19 Use of 11C-methionine PET for decision of discontinuation of adjuvant chemotherapy with temozolomide". Neuro-Oncology Advances 2, Supplement_3 (1 de novembro de 2020): ii14. http://dx.doi.org/10.1093/noajnl/vdaa143.062.
Texto completo da fontePettiwala, Aafrin M., Cathy Pichol-Thievend, Oceane Anezo, Guillaume Bourmeau, Remi Montagne, Anne-Marie Lyne, Pierre-Olivier Guichet Guichet et al. "TMIC-76. GLIOBLASTOMA VESSEL CO-OPTION OCCURS AS A RESISTANCE MECHANISM TO CHEMORADIATION VIA INDUCTION OF A NOVEL CELL STATE". Neuro-Oncology 25, Supplement_5 (1 de novembro de 2023): v295. http://dx.doi.org/10.1093/neuonc/noad179.1141.
Texto completo da fonteLee, Jae-Myeong, Bong-Wan Kim, Wook Hwan Kim, Hee-Jung Wang e Myung Wook Kim. "Clinical Implication of Bile Spillage in Patients Undergoing Laparoscopic Cholecystectomy for Gallbladder Cancer". American Surgeon 77, n.º 6 (junho de 2011): 697–701. http://dx.doi.org/10.1177/000313481107700623.
Texto completo da fonteBelokon, S. V., I. A. Gulidov, D. V. Gogolin, K. E. Medvedeva, S. A. Ivanov e A. D. Kaprin. "Re-irradiation combined with bevacizumab in the treatment of glioblastoma recurrence". Siberian journal of oncology 23, n.º 1 (21 de março de 2024): 142–54. http://dx.doi.org/10.21294/1814-4861-2024-23-1-142-154.
Texto completo da fonteCianci, Francesca, Guido Rey, Dietmar Krex, Davide Ceresa, Paolo Malatesta e Michele Mazzanti. "Abstract 2092: Genomic and proteomic analysis of glioblastoma recurrences during TTFields exposure". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 2092. http://dx.doi.org/10.1158/1538-7445.am2024-2092.
Texto completo da fonteSimionescu, Natalia, Miruna Nemecz, Anca-Roxana Petrovici, Ioan Sebastian Nechifor, Razvan-Cristian Buga, Marius Gabriel Dabija, Lucian Eva e Adriana Georgescu. "Microvesicles and Microvesicle-Associated microRNAs Reflect Glioblastoma Regression: Microvesicle-Associated miR-625-5p Has Biomarker Potential". International Journal of Molecular Sciences 23, n.º 15 (29 de julho de 2022): 8398. http://dx.doi.org/10.3390/ijms23158398.
Texto completo da fonteNakao, Sayumi, Michio Itabashi, Mamiko Ubukata, Yoshiko Bamba, Tomoichiro Hirosawa, Shimpei Ogawa, Shingo Kameoka e Kenichi Sugihara. "Age-specific prognostic factors in patients treated surgically for pulmonary metastases of colorectal cancer: A multi-institutional cumulative follow-up study." Journal of Clinical Oncology 33, n.º 3_suppl (20 de janeiro de 2015): 773. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.773.
Texto completo da fontePichol-Thievend, C., O. Anezo, A. M. Pettiwala, G. Bourmeau, R. Montagne, A. Lyne, P. Guichet et al. "OS07.5.A GLIOBLASTOMA VESSEL CO-OPTION AND TRANSITION TO A RESISTANT CELL STATE ARE INDUCED BY CHEMORADIATION". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii18. http://dx.doi.org/10.1093/neuonc/noad137.052.
Texto completo da fonteTan, David, Imogen Roth, Agadha Wickremesekera, Paul Davis, Andrew Kaye, Theo Mantamadiotis, Stanley Stylli e Swee Tan. "Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System". Cells 8, n.º 11 (31 de outubro de 2019): 1364. http://dx.doi.org/10.3390/cells8111364.
Texto completo da fonteCentonze, Giovanni, Alessandro Mangogna, Tiziana Salviato, Beatrice Belmonte, Laura Cattaneo, Melissa Anna Teresa Monica, Giovanna Garzone et al. "Gastroblastoma in Adulthood—A Rarity among Rare Cancers—A Case Report and Review of the Literature". Case Reports in Pathology 2019 (28 de novembro de 2019): 1–6. http://dx.doi.org/10.1155/2019/4084196.
Texto completo da fonteObrador, Elena, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Lara Gutiérrez-Arroyo, Alba Loras et al. "Glioblastoma Therapy: Past, Present and Future". International Journal of Molecular Sciences 25, n.º 5 (21 de fevereiro de 2024): 2529. http://dx.doi.org/10.3390/ijms25052529.
Texto completo da fonteChirica, Costin, Danisia Haba, Elena Cojocaru, Andreea Isabela Mazga, Lucian Eva, Bogdan Ionut Dobrovat, Sabina Ioana Chirica, Ioana Stirban, Andreea Rotundu e Maria Magdalena Leon. "One Step Forward—The Current Role of Artificial Intelligence in Glioblastoma Imaging". Life 13, n.º 7 (14 de julho de 2023): 1561. http://dx.doi.org/10.3390/life13071561.
Texto completo da fonteO’Rawe, Michael, Ethan J. Kilmister, Theo Mantamadiotis, Andrew H. Kaye, Swee T. Tan e Agadha C. Wickremesekera. "The Renin–Angiotensin System in the Tumor Microenvironment of Glioblastoma". Cancers 13, n.º 16 (9 de agosto de 2021): 4004. http://dx.doi.org/10.3390/cancers13164004.
Texto completo da fonteHamza, Mohamed Ali, Jacob Mandel, Charles A. Conrad, Mark R. Gilbert, W. K. Alfred Yung, Vinay K. Puduvalli e John Frederick De Groot. "Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 2042. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2042.
Texto completo da fonteChédeville, Agathe L., e Patricia A. Madureira. "The Role of Hypoxia in Glioblastoma Radiotherapy Resistance". Cancers 13, n.º 3 (1 de fevereiro de 2021): 542. http://dx.doi.org/10.3390/cancers13030542.
Texto completo da fonteStephenson, Connor, Daniel G. McDonald, Milad Yazdani, Shikhar Mehrotra, Cynthia A. Welsh, Libby Kosnik Infinger, William A. Vandergrift et al. "NIMG-78. DEVELOPMENT OF A PRECLINICAL GLIOBLASTOMA MURINE MODEL FOR THE ASSESSMENT OF RADIATION NECROSIS USING DIFFUSION KURTOSIS IMAGING". Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii183. http://dx.doi.org/10.1093/neuonc/noac209.696.
Texto completo da fonteAntipina, N., A. Belyashova, G. Pavlova, A. Nikolaeva, E. Savchenko, A. Ovechkina, D. Shamadykova e A. Golanov. "P02.02 Modeling of response to irradiation in recurrence glioblastoma’s cells culture". Neuro-Oncology 23, Supplement_2 (1 de setembro de 2021): ii17. http://dx.doi.org/10.1093/neuonc/noab180.055.
Texto completo da fonteAkhunbay-Fudge, Christopher Yusuf, Kevin Critchley, Ryan Mathew e Heiko Wurdak. "CCRG-04. AUTOMATED REAL TIME TRACKING OF GLIOBLASTOMA CELL CYCLE TRANSITIONS IN ASSEMBLOIDS LINKS G2 CELLS TO INFILTRATION". Neuro-Oncology 25, Supplement_5 (1 de novembro de 2023): v39. http://dx.doi.org/10.1093/neuonc/noad179.0153.
Texto completo da fonteWang, Xiaowen, Matias Bustos, Xiaoqing Zhang, Romela Ramos, Cong Tan, Yuuki Iida, Shu-Ching Chang et al. "Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors". Cancers 12, n.º 5 (27 de abril de 2020): 1081. http://dx.doi.org/10.3390/cancers12051081.
Texto completo da fonteLessi, Francesca, Sara Franceschi, Mariangela Morelli, Michele Menicagli, Francesco Pasqualetti, Orazio Santonocito, Carlo Gambacciani et al. "Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background". Cells 11, n.º 7 (26 de março de 2022): 1127. http://dx.doi.org/10.3390/cells11071127.
Texto completo da fonteAttia, Noha, Mohamed Mashal, Sudhakar Pemminati, Adekunle Omole, Carolyn Edmondson, Will Jones, Priyanka Priyadarshini et al. "Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies". Cells 11, n.º 1 (30 de dezembro de 2021): 116. http://dx.doi.org/10.3390/cells11010116.
Texto completo da fontePatrón, Lilian A., Helen Yeoman, Sydney Wilson, Nanyun Tang, Michael E. Berens, Vijay Gokhale e Teri C. Suzuki. "Novel Brain-Penetrant, Small-Molecule Tubulin Destabilizers for the Treatment of Glioblastoma". Biomedicines 12, n.º 2 (9 de fevereiro de 2024): 406. http://dx.doi.org/10.3390/biomedicines12020406.
Texto completo da fonteComas Antón, S., S. Moreno, M. Antelo, C. Carrato, C. Balaña, S. Castañer, A. Hernández, C. Hostalot, M. Domenech e S. Villà. "P11.30.A LONG-TERM SURVIVING GLIOBLASTOMA. CLINICAL, MOLECULAR AND SURVIVAL ANALYSES". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii80. http://dx.doi.org/10.1093/neuonc/noad137.264.
Texto completo da fonteBourmeau, G., O. Anezo, A. Ballestin, C. Pichol-Thievend, J. Reveilles e G. Seano. "OS07.7.A GLIOBLASTOMA HYBRID CELL STATE CONVEYS RESISTANCE TO CONVENTIONAL THERAPIES". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii18—ii19. http://dx.doi.org/10.1093/neuonc/noad137.054.
Texto completo da fonteMorelli, M., F. Lessi, M. Giacomarra, A. Marranci, M. Menicagli, O. S. Santonocito, P. Aretini et al. "P17.16.B INVESTIGATION OF REGORAFENIB TUMOR SENSITIVITY AND UNDERLYING TREATMENT INDUCED MOLECULAR MECHANISMS IN GLIOBLASTOMA RECURRENT TUMORS". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii120—ii121. http://dx.doi.org/10.1093/neuonc/noad137.406.
Texto completo da fonteLin, Chao-Qun, e Lu-Kui Chen. "Effect of differential hypoxia-related gene expression on glioblastoma". Journal of International Medical Research 49, n.º 5 (maio de 2021): 030006052110137. http://dx.doi.org/10.1177/03000605211013774.
Texto completo da fonteZimmer, Niklas, Emily R. Trzeciak, Andreas Müller, Philipp Licht, Bettina Sprang, Petra Leukel, Volker Mailänder et al. "Nuclear Glycoprotein A Repetitions Predominant (GARP) Is a Common Trait of Glioblastoma Stem-like Cells and Correlates with Poor Survival in Glioblastoma Patients". Cancers 15, n.º 24 (5 de dezembro de 2023): 5711. http://dx.doi.org/10.3390/cancers15245711.
Texto completo da fonteCardoso, Ana M., Catarina M. Morais, Frederico Pena, Tânia Marante, Pedro P. Cunha, Amália S. Jurado e Maria C. Pedroso de Lima. "Differentiation of glioblastoma stem cells promoted by miR-128 or miR-302a overexpression enhances senescence-associated cytotoxicity of axitinib". Human Molecular Genetics 30, n.º 3-4 (12 de janeiro de 2021): 160–71. http://dx.doi.org/10.1093/hmg/ddab011.
Texto completo da fonteLucas Calduch, A., M. Macià Garau, S. Villà Freixa, G. Plans Ahicart, C. Mesía Barroso, C. Majós Torró, A. Pons Escoda et al. "P17.09.B REIRRADIATION AS A SALVAGE THERAPY FOR LOCAL GLIOBLASTOMA RECURRENCE". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii118—ii119. http://dx.doi.org/10.1093/neuonc/noad137.399.
Texto completo da fonteClavreul, Anne, Lila Autier, Jean-Michel Lemée, Paule Augereau, Gwénaëlle Soulard, Luc Bauchet, Dominique Figarella-Branger, Philippe Menei e FGB Network. "Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?" Cancers 14, n.º 22 (9 de novembro de 2022): 5510. http://dx.doi.org/10.3390/cancers14225510.
Texto completo da fonteVilarino, Noelia, Neus Martinez-Bosch, Carmen Balana, Francesc Alameda, Anna Estival, Estela Pineda, Sonia del Barco et al. "Galectin-1 (Gal-1) expression as a prognostic factor in patients with newly diagnosed glioblastoma (GB) treated with Stupp regimen (GLIOCAT study)." Journal of Clinical Oncology 35, n.º 15_suppl (20 de maio de 2017): e13526-e13526. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13526.
Texto completo da fonteLee, Sang Hun, Yong Mi Seol e Dong Uk Kim. "Preoperative risk factors related to relapse-free survival after R0 resection of gallbladder cancer." Journal of Clinical Oncology 42, n.º 3_suppl (20 de janeiro de 2024): 566. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.566.
Texto completo da fonteBynoe, Margaret S. "Glioblastoma usurps host extracellular adenosine to circumvent host anti-tumor Responses". Journal of Immunology 198, n.º 1_Supplement (1 de maio de 2017): 76.17. http://dx.doi.org/10.4049/jimmunol.198.supp.76.17.
Texto completo da fonteHervás-Corpión, Irati, Jorge Navarro-Calvo, Paula Martín-Climent, Marianela Iriarte-Gahete, Noelia Geribaldi-Doldán, Carmen Castro e Luis M. Valor. "Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas". Cells 12, n.º 3 (19 de janeiro de 2023): 374. http://dx.doi.org/10.3390/cells12030374.
Texto completo da fonteSun, Xuheng, Yijun WANG e Yingbin Liu. "Construction and validation of the prognostic model for patients with gallbladder neuroendocrine neoplasm-based a nationwide retrospective registry study." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e16140-e16140. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16140.
Texto completo da fonteTodkar, Sampatti Sambhaji, e Lagdir Appasaheb Gaikwad. "Outcome of suspected H1N1 influenza cases admitted in tertiary care Govt. Hospital Solapur, Maharashtra". Indian Journal of Medical Sciences 69, n.º 1 (28 de março de 2017): 6. http://dx.doi.org/10.18203/issn.0019-5359.indianjmedsci20170482.
Texto completo da fonteMann, Anmol, Nur Safa, Emma Martell, Wenxia Luo, Prasanta Paul, Parandoush Abbasian, Rashid Ahmed et al. "BSCI-07 ACETYL-AMANTADINE AS A DIAGNOSTIC BIOMARKER IN PATIENTS WITH GLIOBLASTOMA". Neuro-Oncology Advances 4, Supplement_1 (1 de agosto de 2022): i2. http://dx.doi.org/10.1093/noajnl/vdac078.007.
Texto completo da fonteSokolov, Dmitry K., Oleg B. Shevelev, Anna S. Khotskina, Alexandra Y. Tsidulko, Anastasia V. Strokotova, Galina M. Kazanskaya, Alexander M. Volkov et al. "Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice". International Journal of Molecular Sciences 24, n.º 12 (16 de junho de 2023): 10243. http://dx.doi.org/10.3390/ijms241210243.
Texto completo da fonteKurz, Sabine K., e Matthias J. Reddehase. "Patchwork Pattern of Transcriptional Reactivation in the Lungs Indicates Sequential Checkpoints in the Transition from Murine Cytomegalovirus Latency to Recurrence". Journal of Virology 73, n.º 10 (1 de outubro de 1999): 8612–22. http://dx.doi.org/10.1128/jvi.73.10.8612-8622.1999.
Texto completo da fonteChernov, Alexandr, Irina Baldueva, Tatyana Nekhaeva, Elvira Galimova, Diana Alaverdian e Olga Shamova. "The molecular mechanisms of multidrug resistance of human glioblastomas". Problems in oncology 67, n.º 1 (4 de março de 2021): 20–28. http://dx.doi.org/10.37469/0507-3758-2021-67-1-20-28.
Texto completo da fonteMendes, Maria, João José Sousa, Alberto Pais e Carla Vitorino. "Targeted Theranostic Nanoparticles for Brain Tumor Treatment". Pharmaceutics 10, n.º 4 (9 de outubro de 2018): 181. http://dx.doi.org/10.3390/pharmaceutics10040181.
Texto completo da fonteBallestín, A., C. Pichol-Thievend, G. Bourmeau, B. Blanchard, A. Pettiwala, J. Reveilles, S. Leboucher, O. Anezo e G. Seano. "P10.20.B POSTOPERATIVE ISCHEMIA CAUSED BY MICROSURGICAL RESECTION PROMOTES PRONEURAL-TO-MESENCHYMAL TRANSITION IN GLIOBLASTOMA". Neuro-Oncology 25, Supplement_2 (1 de setembro de 2023): ii66—ii67. http://dx.doi.org/10.1093/neuonc/noad137.218.
Texto completo da fonteGiordano, Carolina, Giuseppe Maria Della Pepa, Simona Romano, Laura Marrone, Carlo Maria Donzelli, Maria Fiammetta Romano e Simona Gaudino. "Abstract 5474: Combined use of MRI and TAM analysis in GB monitoring". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5474. http://dx.doi.org/10.1158/1538-7445.am2023-5474.
Texto completo da fonteAntelo, G., I. Valduvieco, S. Comas, S. Serrano, J. Molero, C. Balañá, S. Villà, S. Moreno, M. Mollà e C. Gomà. "P11.36.A Could a transcriptome profile predict local control for glioblastoma?" Neuro-Oncology 24, Supplement_2 (1 de setembro de 2022): ii65. http://dx.doi.org/10.1093/neuonc/noac174.225.
Texto completo da fonteFan, Qing Qing, He Li e Hong Xi Yin. "Study on Optical Performance Monitoring for Fiber-Optical Link Utilizing Chaos Theory". Advanced Materials Research 571 (setembro de 2012): 390–94. http://dx.doi.org/10.4028/www.scientific.net/amr.571.390.
Texto completo da fonteHumphreys, Luke M., Paul Smith, Zhuoyao Chen, Shahd Fouad e Vincenzo D’Angiolella. "The role of E3 ubiquitin ligases in the development and progression of glioblastoma". Cell Death & Differentiation 28, n.º 2 (11 de janeiro de 2021): 522–37. http://dx.doi.org/10.1038/s41418-020-00696-6.
Texto completo da fonteHelaine, Charly, Aurélie E. Ferré, Marine M. Leblond, Elodie A. Pérès, Myriam Bernaudin, Samuel Valable e Edwige Petit. "Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study". Cancers 12, n.º 12 (30 de novembro de 2020): 3585. http://dx.doi.org/10.3390/cancers12123585.
Texto completo da fonte